Comparison of gelatin and HES 130/0.4 solution for fluid resuscitation in children with dengue shock syndrome
| Autor: | Jeanette I. Ch. Manoppo, Merry Mawardi, Novie Homenta Rampengan, T. H. Rampengan |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2013 |
| Předmět: |
Resuscitation
medicine.medical_specialty food.ingredient Respiratory rate lcsh:Medicine Hydroxyethyl starch Hematocrit Gelatin law.invention food Randomized controlled trial law medicine medicine.diagnostic_test business.industry lcsh:R lcsh:RJ1-570 lcsh:Pediatrics Pulse pressure Surgery Hemostasis Anesthesia Pediatrics Perinatology and Child Health dengue shock syndrome resuscitation gelatin HES 130/0.4 business medicine.drug |
| Zdroj: | Paediatrica Indonesiana, Vol 53, Iss 6, Pp 328-33 (2013) |
| ISSN: | 0030-9311 |
| Popis: | Background Dengue shock syndrome (DSS) is characterized by severe vascular leakage and hemostasis disorder, which causes death in 1-5% of cases. World Health Organization management guidelines for fluid resuscitation in DSS remain empirical, rather than evidence-based. Objective To as sess the efficacy of ge latin compared to hydroxyethyl starch (HES) 130/0.4 solution for fluid resuscitation in children with DSS. Methods We performed a multi-centered, randomized study to compare gelatin and HES 130/0.4 solution for resuscitation of children with DSS. We randomly assigned 25 children with DSS to receive gelatin fluid and 25 children to receive HES 130/0.4. Statistical analyses were performed using Chi-square and MannWhitney tests. Results More rapid increase in pulse pressure was noted in subjects treated with HES 130/0.4 compared to those treated with gelatin at 8 hours and 28 hours of therapy (P=0.037 and P=0.048). The decrease in hematocrit in subjects treated with HES 130/0.4 was faster than that of gelatin at 4 hours of therapy (P=0.001). One patient died due to an unusual manifestation of DSS. Respiratory rate decreased faster in subjects treated with HES 130/0.4 than those treated with gelatin at 4 hours and 8 hours of therapy (P< 0.05). Body temperature remained higher in subjects treated with gelatin than HES 130/0.4 at 36 hours and 48 hours of therapy (P< 0.05). However, the decrease in platelet counts in subjects treated with HES 130/0.4 was more than that of gelatin (P=0.018). Conclusion HES 130/0.4 solution may be better for volume replacement compared to gelatin and is safe for fluid resuscitation in children with DSS. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|